Lumenis BE Stellar M22 Multi-Platform Laser System

DEPT OF DEFENSE · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY is soliciting Lumenis BE Stellar M22 Multi-Platform Laser System. Solicitation number HT0014-26-Q-E054. Classified under NAICS 334510 — Electromedical and Electrotherapeutic Apparatus Manufacturing. Product/service code 6515 — MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES. Place of performance: MD, USA. Responses are due by 24 September 2026 13:00 UTC. Posted on SAM.gov, the US federal contract opportunities system; registration is required to bid.

Solicitation Number: HT0014-26-Q-E054

Contracting Activity: Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - Northeast (HCD-NE) in support of the White House Medical Unit (WHMU).

Title: Procurement of Two (2) Lumenis BE Stellar M22 Multi-Application Laser/IPL Platforms (Brand Name or Equal)

Classification Code (PSC): 6515 – Medical and Surgical Instruments, Equipment, and Supplies

NAICS Code: 334510 – Electromedical and Electrotherapeutic Apparatus Manufacturing

Small Business Size Standard: 1,250 Employees

Set-Aside Status: 100% Total Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside

Notice Type: Combined Synopsis / Solicitation

Original Published Date: September 18, 2026

Response Date / Local Time: September 24, 2026, 09:00 (9:00 AM) Eastern Time

Anticipated Award / Effective Date: September 30, 2026

1. GENERAL INFORMATION & DESCRIPTION

This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This acquisition is conducted under FAR Part 12 (Acquisition of Commercial Products and Commercial Services) and utilizes the simplified procedures authorized under FAR Subpart 13.5 (Simplified Procedures for Certain Commercial Items). This announcement constitutes the only solicitation; quotes are being requested and a separate written solicitation will not be issued. This acquisition is issued as a Request for Quotes (RFQ) under RFQ number HT0014-26-Q-E054. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2026-01 / Defense Federal Acquisition Regulation Supplement (DFARS) current edition. This procurement is 100% Set-Aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) under NAICS code 334510 (size standard: 1,250 employees). Only businesses certified by the Small Business Administration (SBA) in the Veteran Small Business Certification (VetCert) program at the time of quote submission and award are eligible to compete. The Nonmanufacturer Rule (13 CFR 121.406 / FAR 52.219-33) applies. Quoters must provide an official, current letter signed by Lumenis Be, Inc. confirming that the offeror is an authorized distributor/reseller entitled to furnish the specified systems, provide genuine OEM parts, and guarantee full factory warranty and OEM-certified service backing.

2. CONTRACT LINE-ITEM NUMBER (CLIN) SCHEDULE

The Government intends to award a single Firm-Fixed-Price (FFP) contract resulting from this solicitation.

3. SALIENT CHARACTERISTICS (FAR 52.211-6: BRAND NAME OR EQUAL)

The White House Medical Unit requires two (2) multi-application dermatological laser/light console platforms to deliver advanced cutaneous, vascular, pigmented lesion, and skin resurfacing treatment. The baseline performance is established by the Lumenis BE Stellar M22 Platform System. Any offeror proposing an "Equal" product must provide technical documentation, engineering specifications, and descriptive literature verifying that the offered system satisfies every salient characteristic listed below:

Salient Characteristics:

Clinical performance

• Optical spectrum 400 to 1200 nm with interchangeable cut-off filters. Filters

available: 515, 560, 590, 615, 640, 695, 755 nm, plus dual-band filters for acne and

vascular presets

• Multiple Sequential Pulsing for controlled epidermal heating and vascular selectivity
• Fluence range with fine 0.5 to 1.0 J/cm² increments
• Pulse duration 2 to 20 ms with adjustable intra-pulse delay 5 to 150 ms to enable subpulsing.
• Sapphire lightguides with verified coupling and spot sizes: 8 × 15 mm, 15 × 35 mm,

and 6 mm round.

• 850+ Preset protocols by indication and skin type

Patient safety and comfort

• Sapphire contact cooling at >10 degrees
• Interlocks, error prompts, and SW safety
• Compatibility with periocular workflows where indicated

Workflow and throughput

• Glide Mode for faster coverage on large areas
• Short operator learning curve with standardized parameters

Quiet operation suited to multi-room deployment

• Generic power outlet

Usability and training

• 8 filters for quick change of wavelength
• On-screen guidance and treatment libraries
• Long lightguides for increased visibility
• 3 buttons operating modes
• Vendor training with competency sign-offs and checklists

Integration and compliance IEC 60601 electrical safety and EMC compliant

• Hospital-friendly policies supported by system safeguards
• Prescription use device with labeling controls, validated software risk management,

and patient/operator eye protection requirements Economics

• Low disposables burden with reusable lightguides
• Reduced per-treatment cost for high-volume clinics
• Reduced per-treatment numbing with glide mode
• Reduced treatment time with glide mode

Service and reliability

• Robust metal chassis and protected lightguides for high duty use

Data and QA

• Real-time energy monitoring and shot counters
• Exportable treatment logs for QA audits and credentialing

5. INSTRUCTIONS TO OFFERORS & SUBMISSION DEADLINE

Quotes must be submitted electronically via email to  Contract Specialist Judith Meynard at [contact details removed] and Contracting Officer Mr. Gregory M. Crump at [contact details removed] no later than  September 24, 2026, at 09:00 (9:00 AM) Eastern Time. The email subject line must reference: Quote Submission - RFQ HT0014-26-Q-E054 - [Offeror Name].

Submissions must include:

• Socioeconomic Proof: SBA VetCert certification letter or official profile verification showing active SDVOSB certification under NAICS 334510.
• Technical Submission: Product literature, technical cut-sheets, FDA 510(k) documentation, and (if quoting an "Equal" product) an itemized Salient Characteristics Compliance Matrix.
• Price Quote: Total proposed price evaluated as the aggregate sum of the base equipment and all post-warranty maintenance option periods.

6. EVALUATION FACTORS (LOWEST PRICE TECHNICALLY ACCEPTABLE)

Award will be made to the responsible offeror whose quotation conforms to all solicitation terms and conditions and represents the Lowest Price Technically Acceptable (LPTA):

• Socioeconomic Eligibility (Pass/Fail): Valid SBA VetCert SDVOSB certification under NAICS 334510 and NMR compliance.
• Technical Acceptability (Pass/Fail): Conformance to all salient characteristics in Section 3 and delivery capability within 30 days ARO.
• Price: For all quotes deemed Technically Acceptable, the Government will evaluate total price for reasonableness. Total evaluated price will be calculated as the sum of CLINs 0001, 1002 and 2002.